fatty acid oxidation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-10-29. Anything still debated is marked as such rather than presented as settled.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid metabolism |
| Preclinical effect | Increased fatty acid oxidation | Observed in rodent studies |
| Key safety signal | Tumors in rodents after long-term exposure | Contributed to halted clinical development |
| Human trial status | No approved product; development stopped | Limited short-term metabolic data |
| Sport regulatory status | Prohibited at all times | WADA hormone and metabolic modulators class |
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
== Treatment == Muscle atrophy can be delayed, prevented and sometimes reversed with treatment. Treatment approaches include impacting the signaling pathways that induce muscle hypertrophy or slow muscle breakdown as well as optimizing nutritional status. Physical activity provides a significant anabolic muscle stimulus and is a crucial component to slowing or reversing muscle atrophy. It is still unknown regarding the ideal exercise "dosing." Resistance exercise has been shown to be beneficial in reducing muscle atrophy in older adults. In patients who cannot exercise due to physical limitations such as paraplegia, functional electrical stimulation can be used to externally stimulate the muscles. Adequate calories and protein is crucial to prevent muscle atrophy. Protein needs may vary dramatically depending on metabolic factors and disease state, so high-protein supplementation may be beneficial. Supplementation of protein or branched-chain amino acids, especially leucine, can provide a stimulus for muscle synthesis and inhibit protein breakdown and has been studied for muscle atrophy for sarcopenia and cachexia. β-Hydroxy β-methylbutyrate (HMB), a metabolite of leucine which is sold as a dietary supplement, has demonstrated efficacy in preventing the loss of muscle mass in several muscle wasting conditions in humans, particularly sarcopenia. Based upon a meta-analysis of seven randomized controlled trials that was published in 2015, HMB supplementation has efficacy as a treatment for preserving lean muscle mass in older adults.
1993/1947) Learning for Work (Miscellaneous Provisions) Order 1993 (S.I. 1993/1949) Act of Adjournal (Consolidation Amendment) (Courses for Drink-drive Offenders) 1993 (S.I. 1993/1955) Act of Sederunt (Sheriff Court Ordinary Cause Rules) 1993 (S.I. 1993/1956) Double Taxation Relief (Taxes on Income) (General) (Manufactured Overseas Dividends) Regulations 1993 (S.I. 1993/1957) Dartford–Thurrock Crossing (Amendment) Regulations 1993 (S.I. 1993/1961) Harwich Haven Harbour Revision Order 1993 (S.I. 1993/1962) A4 Trunk Road (Great West Road, Hounslow) (Prescribed Routes) Order 1993 (S.I. 1993/1963) London South Circular Trunk Road (A205) (Westhorne Avenue, Lewisham) (Prohibition of Use of Gaps in Central Reserve) Order 1993 (S.I. 1993/1964) Civil Aviation (Route Charges for Navigation Services) Regulations 1993 (S.I. 1993/1965) Importation of Bovine Semen (Amendment) Regulations 1993 (S.I. 1993/1966) Animals and Animal Products (Import and Export) (Amendment) Regulations 1993 (S.I. 1993/1967) Criminal Justice Act 1993 (Commencement No. 1) Order 1993 (S.I. 1993/1968) Education (Teachers) (Amendment) Regulations 1993 (S.I. 1993/1969) Clyde Port Authority (Dissolution) Order 1993 (S.I. 1993/1970) Education Act 1993 (Commencement No. 1 and Transitional Provisions) Order 1993 (S.I. 1993/1975) Education (London Oratory School) (Exemption from Pay and Conditions Orders) Order 1993 (S.I. 1993/1976) Further Education (Attribution of Surpluses and Deficits) (The Ridge College) Regulations 1993 (S.I.
=== Similar species === In Europe, the spring-fruiting Amanita verna is a similar all-white species, as is the autumn-fruiting, white form of Amanita phalloides (deathcap). Both are equally poisonous. In their immature, button-mushroom stage, all these poisonous species could be mistaken for young, white-capped, edible mushrooms (Agaricus species), highlighting the danger of picking immature fruit bodies for food. In general, there are about 22 species that are considered destroying angels.
Sources: en.wikipedia.org
== Mechanisms == There are two known mechanisms for RNA helicase unwinding: canonical duplex unwinding and unwinding by local strand separation. During canonical duplex unwinding, the helicase first binds to the single stranded region, then uses ATP hydrolysis as a power stroke in order to translocate the helicase across the strand. As the helicase slides down one strand, it is dissociating the two strands and removing the complementary. Finally, the helicase is removed.
Grace pleads for his understanding of her actions and then tells him of her mother's involvement in necromancy and her plans against Nephilim. She forces her bracelet back on his wrist and asks that he go to Blackthorn Manor to destroy an automaton there. With the bracelet's control strengthened, James agrees and in the process of destroying it, burns down the manor. At the following council meeting, Tatiana accuses James of having orchestrated the Mandikhor attacks and then burning her house down to destroy her evidence. In an effort to protect him, Cordelia provides him with an alibi, claiming he had been with her the night before, tarnishing her reputation. While Tatiana is being arrested and sent to the Adamant Citadel for the dark magic items found in the rubble of her home, James proposes to Cordelia in order to save her reputation, with the plan to divorce in a year, and Cordelia agrees. At James and Cordelia's engagement party, Matthew drinks heavily in an attempt to drown his sorrows, realizing he is in love with Cordelia. Charles announces his engagement to Grace and later seeks out Alastair, who breaks up with him in a lone corridor with Cordelia there to support him. Because of his drunken state, Matthew reveals the rumors Alastair had spread about their parents to Thomas, in an effort to prevent their friendship, causing Thomas to threaten Alastair, who runs out of the room crying. Ariadne approaches Anna, telling her that she heard her when she spoke to her at the infirmary, making Ariadne realize that Anna still loved her.
=== Appearance and odour === Mephedrone is a white substance. It is sold most commonly as crystals or a powder, but also in the form of capsules or pills. It can have a distinctive odour, reported to range the smell of vanilla and bleach, stale urine, or electric circuit boards. Synthesis byproducts or other contaminants are likely responsible for this, as the molecule itself is not an odorant.
==== Shortage of 237Np stockpiles ==== The long half-life (88 years) of 238Pu and the absence of γ-radiation that could interfere with the operation of on-board electronic components, or irradiate people, makes it the radionuclide of choice for electric thermogenerators. 237Np is therefore a key radionuclide for the production of 238Pu, which is essential for deep space probes requiring a reliable and long-lasting source of energy without maintenance. Stockpiles of 238Pu built up in the United States since the Manhattan Project, thanks to the Hanford nuclear complex (operating in Washington State from 1943 to 1977) and the Savannah River Site (operating in South Carolina from 1950 to 1988) the development of atomic weapons, are now almost exhausted. The extraction and purification of sufficient new quantities of 237Np from irradiated nuclear fuels is therefore necessary for the resumption of 238Pu production in order to replenish the stocks needed for space exploration by robotic probes.
Sources: en.wikipedia.org
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.
Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.
Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.
Yes, WADA prohibits cardarine as a PPARδ agonist. It appears on the prohibited list and can be detected in urine or blood. Athletes using it risk sanctions.